Blood pool MR contrast agents for cardiovascular imaging

Journal of Magnetic Resonance Imaging

Volumn 12, Issue 6, 2000, Pages 890-898

  Saeed, Maythem ^a,b   Wendland, Michael F ^a   Higgins, Charles B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Blood pool MR contrast agents; Ischemic heart disease; MR angiography

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM CHELATE; SUPERPARAMAGNETIC IRON OXIDE;

ANGIOGRAPHY; BLOOD VESSEL PERMEABILITY; CARDIOVASCULAR SYSTEM; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; HEART MUSCLE PERFUSION; ISCHEMIC HEART DISEASE; MAGNETIC RESONANCE ANGIOGRAPHY; PRIORITY JOURNAL; REVIEW;

AORTA, ABDOMINAL; CAPILLARY PERMEABILITY; CONTRAST MEDIA; CORONARY DISEASE; HEMODYNAMIC PROCESSES; HUMANS; ISCHEMIA; LEG; MAGNETIC RESONANCE ANGIOGRAPHY; PULMONARY EMBOLISM;

EID: 0033645972     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/1522-2586(200012)12:6<890::AID-JMRI12>3.0.CO;2-K     Document Type: Review

References (66)

1. Breath-hold ultrafast three-dimensional gadolinium-enhanced MR angiography of the aorta and renal and other visceral abdominal arteries
2. Steady-state and dynamic MR angiographic imaging with MS-325: Initial experience in humans
3. Ultrasmall super paramagnetic iron oxide to enhance MRA of the renal and coronary arteies: Studies in human patients
4. Safety and preliminary findings with the intravascular contrast agent NC 100150 injection for MR coronary angiography
5. MS-325: Albumin-targeted contrast agent for MR angiography
6. Coronary arteries: Breath-hold, gadolinium-enhanced, three dimensional MR angiography
7. Current developments and future direction of coronary magnetic resonance angiography
8. Gadolinium enhanced MR coronary artery imaging: Mode of slow infusion
9. Comparison of intravascular and extravascular contrast agents in coronary artery imaging
10. Improved contrast enhancement in coronary trees imaging using dual-enhanced breath-hold three-dimensional spoiled gradient-echo MRA with ECG-gating
11. Three-dimensional MR imaging of coronary arteries using an intravascular contrast agent
12. Contrast enhanced magnetic resonance imaging of the coronary arteries
13. Physical principles of magnetic resonance angiography
14. Contrast-enhanced magnetic resonance angiography in the coronary and peripheral arteries
15. Pulmonary embolism: Validation of spiral CT angiography in 149 patients
16. Pulmonary embolism: Prospective comparison of spiral CT with ventilation-perfusion scintigraphy
17. Pulmonary embolism: Diagnosis with contrast enhanced electron-beam CT and comparison with pulmonary angiography
18. Single breath-hold pulmonary magnetic resonance angiography
19. Pulmonary perfusion: Qualitative assessment with dynamic contrast enhanced MRI using ultrashort TE and inversion recovery turbo FLASH
20. Contrast enhanced, ultrafast 3D pulmonary MR angiography in a single breath hold: Initial assessment of imaging performance
21. Three-dimensional MR imaging of pulmonary vessels and Parenchyma with NC100150 injection (Clariscan(TM))
22. Pulmonary perfusion and angiography: Evaluation with breath hold enhanced three dimensional fast imaging steady state percession MR imaging with short TR and TE
23. Pulmonary MR angiography with blood pool contrast agent: Effect of dose, echo time, and flip angle on vascular enhancement
24. Contrast enhanced MR imaging of the lung: Assessment of ventilation and perfusion
25. Gd-DTPA-polylysine-enhanced pulmonary time-of-flight MR angiography
26. Detection of pulmonary emboli using MR angiography with MPEG-PL-GdDTPA: An experimental study in rabbits
27. Value of blood pool contrast agents in magnetic resonance angiography of the pelvis and lower extremities
28. Use of magnetic particles for sensitizing MR images to blood flow
29. Use of an intravascular T1 contrast agent to improve MR cine myocardial-blood pool definition in man
30. Contrast-enhanced 3D-TOF MRA of peripheral vessels: Intravascular versus extravascular MR contrast media
31. MR angiography with gadolinium dimeglumine-polylysine: Evaluation in rabbits
32. MR contrast material for vascular enhancement: Value of superparamagnetic iron oxide
33. Displays for MR angiography
34. Improved MR angiography: Magnetization transfer suppression with variable flip angle excitation and increased resolution
35. Evaluation of the effects of intravascular MR contrast media (gadolinium Dendrimer) on 3D time of flight magnetic resonance angiography of the body
36. Abdominal MR angiography performed using blood pool agents: Comparison of a new superparamagnetic iron oxide nanoparticle and a linear gadolinium polymer
37. Magnetic resonance angiography with Gadomer-17
38. Assessment of myocardial salvage after ischemia and reperfusion using magnetic resonance imaging and spectroscopy
39. Occlusive and reperfused myocardial infarction: Detection by using MR imaging with gadolinium polylysine enhancement
40. Myocardial infarction: Assessment with an intravascular MR contrast medium
41. Histologic confirmation of microvascular hyperpermeability to macromolecular MR contrast medium in reperfused myocardial infarction
42. Influence of the severity of myocardial injury on the distribution of macromolecules: Extra versus intra-vascular gadolinium-based MR contrast agents
43. Microvascular injury in reperfused infarcted myocardium: Noninvasive assessment with contrast-enhanced echoplanar magnetic resonance imaging
44. Evidence that accumulation of Gd-DTPA-albumin in postischemic myocardium is associated with myocardial edema rather than infarction
45. Magnetic resonance perfusion imaging
46. Contrast-enhanced MR angiography and first pass renal perfusion imaging using MS-325, an intravascular contrast agent
47. Accuracy of modeling of regional myocardial flows from residue functions of an intravascular indicator
48. Concepts of myocardial perfusion imaging in magnetic resonance imaging
49. Superparamagnetic iron oxide particles and positive enhancement for myocardial perfusion studies assessed by subsecond T1-weighted MRI
50. Identification of myocardial reperfusion with echo planar magnetic resonance imaging: Discrimination between occlusive and reperfused infarctions
51. Contrast enhanced first pass myocardial perfusion imaging: Correlation between myocardial blood flow in dogs at rest and during hyperemia
52. Regional myocardial blood volume estimated with MR first pass imaging and polylysine-GdDTPA in the dog
53. Myocardial perfusion and function in dogs with moderate coronary stenosis
54. MR first pass imaging: Quantitative assessment of transmural perfusion and collateral flow
55. Quantification of tissue plasma volume in the rat by contrast-enhanced magnetic resonance imaging
56. MRI of acute myocardial ischemia; comparing a new contrast agent, Gd-DTPA-24-cascade-polymer, with Gd-DTPA
57. Magnetic resonance imaging of acute myocardial infarction: In vivo detection using polylysine-(gadolinium-DTPA)
58. 24-Gd-DTPA-cascade polymer: A novel intravascular relaxation contrast agent for cardiac MR first pass imaging
59. Lack of myocardial perfusion immediately after successful thrombolysis: A predictor of poor recovery of left ventricular function in anterior myocardial infarction
60. Myocardial contrast echocardiography: Development, applications and future directions
61. Progressive failure of coronary flow during reperfusion of myocardial infarction: Documentation of the no-reflow phenomenon with positron emission tomography
62. T1-relaxation kinetics of extracellular, intracellular and intravascular MR contrast agents in normal and acutely reperfused myocardium using echo-planar MR imaging
63. The 'no-reflow' phenomenon after temporary coronary occlusion in the dog
64. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction
65. Contrast-enhanced magnetic resonance angiography of carotid arterial wall in pigs